Chronic pain influences around 20% of the populace all over the world, and many patients working experience its detrimental effects on their quality of life and mental health. Ketamine, an NMDA antagonist that also acts on opioid receptors, has been examined being a pharmacologic option for chronic pain disorders. RCTs https://ignacyv002xnb1.ltfblog.com/profile